EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Claudio Muneretto
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muneretto, C.
Right arrow Articles by Cas, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muneretto, C.
Right arrow Articles by Cas, L. D.
Related Collections
Right arrow Coronary disease

Eur J Cardiothorac Surg 2003;23:657-664
© 2003 Elsevier Science NL


Is total arterial myocardial revascularization with composite grafts a safe and useful procedure in the elderly?

Claudio Munerettoa*, Alberto Negria, Gianluigi Bisleria, Jacopo Manfredia, Alberto Terrinia, Marco Metrab, Savina Nodarib, Livio Dei Casb

a Department of Cardiac Surgery, University of Brescia Medical School, Brescia, Italy
b Department of Cardiology, University of Brescia Medical School, Brescia, Italy

Received 25 September 2002; received in revised form 20 January 2003; accepted 3 February 2003.

* Corresponding author. UDA Cardiochirurgia, Spedali Civili di Brescia, P.le Spedali Civili, 1, 25123 Brescia, Italy. Tel.: +39-30-399-6401; fax: +39-30-399-6096
e-mail: munerett{at}master.cci.unibs.it


    Abstract
 Top
 Abstract
 1. Introduction
 2. Materials and methods
 3. Results
 4. Discussion
 Appendix A. Conference...
 References
 
Objective: The aim of the study was to evaluate the mid-term results of total arterial myocardial revascularization (TAMR) with composite grafts in patients older than 70 years when compared to standard CABG technique, since the usefulness of TAMR in the elderly has not been demonstrated yet. Methods: A prospective randomized study was designed with the following end-points: post-operative complications, death, recurrence of angina, graft occlusion, any cardiac event and reinterventions. One hundred and eighty-eight patients older than 70 years were enrolled and assigned to Group 1(G1)=94 pts, for total arterial revascularization or Group 2(G2)=94 pts, for standard CABG (LITA on LAD plus additional saphenous veins). The groups were comparable in terms of pre-operative characteristics and Euroscore (mean: G1=8.4 vs. G2=8.2). Results: No differences between the groups were observed in terms of mean number of grafted vessels (G1=2.1 vs. G2=2.3), mean aortic cross-clamping time (G1=34±8 vs. G2=33±6 min), mechanical ventilation time (G1=23±4 vs. G2=22±4 hr), ICU stay (G1=40±10 vs. G2=39±9 hr), post-operative complications and hospital mortality (G1=5.3% vs. G2=4.2%). At a mean follow-up of 12±4 months, cumulative incidence of angina recurrence was 2.1% in G1 vs. 11% in G2 (P=0.021). Angiographic evaluation showed 98.2% arterial patency in G1 vs. 86% saphenous vein graft patency in G2 (P<0.001). Multivariate analysis identified conventional CABG surgery as independent predictor of angina recurrence, graft occlusion and late cardiac events. Conclusions: Total arterial revascularization with composite grafts proved to be a safe and effective procedure also in the elderly. Composite arterial grafts provided superior clinical outcome with a lower rate of angina recurrence, graft occlusion and late cardiac events when compared to conventional CABG strategy.

Key Words: CABG surgery • Arterial conduits • Composite grafts • Elderly patients


    1. Introduction
 Top
 Abstract
 1. Introduction
 2. Materials and methods
 3. Results
 4. Discussion
 Appendix A. Conference...
 References
 
During the last two decades, the percentage of patients older than 70 years requiring coronary surgery steadily increased worldwide [1,2]. Several studies reported that hospital morbidity and mortality of this subset population were higher than those for younger patients. The higher operative risk in elderly seems to be not solely due to the aging process but mainly related to associated comorbidities [2,3]. The use of internal thoracic arteries (ITAs) has been demonstrated to improve the long-term benefits of coronary artery bypass grafting (CABG) surgery [4], however, in the elderly population, saphenous vein grafts have been extensively used and considered as a first choice conduit. Reluctance to use arterial conduits in elderly was mainly related to concerns about long-term survival of this cohort of patients with several associated comorbidities. In addition, many surgeons assumed that the use of ITA and/or other arterial grafts may be associated with an increased morbidity and mortality due to excessive surgical invasiveness and prolonged operative time [5].

An increasing number of authors reported that total arterial revascularization may improve the clinical outcome of patients when compared to conventional CABG surgery (LITA on LAD plus additional saphenous vein grafts (SVG)) [4,6]. However, the advantages of total arterial grafting in the elderly have not been demonstrated yet. The aim of the present study was to evaluate at short and mid term the safety and usefulness of total arterial revascularization with composite grafts in patients aging over 70 years.


    2. Materials and methods
 Top
 Abstract
 1. Introduction
 2. Materials and methods
 3. Results
 4. Discussion
 Appendix A. Conference...
 References
 
2.1. Patient selection
We enrolled 188 patients older than 70 years of age scheduled for CABG surgery and assigned them at random to Group 1 (G1: 94 pts) undergoing total arterial myocardial revascularization (TAMR) with composite grafts and to Group 2 (G2: 94 pts) receiving conventional CABG surgery (LITA on LAD plus additional saphenous vein grafts). We excluded from the study patients with left ventricular ejection fraction less than 25%, emergency operations, single vessels disease, patients with diffuse atherosclerosis of the ascending aorta and high risk patients with Euroscore >10. The study protocol was approved by the Institutional Ethics Committee and informed consent specific to the type of surgery was obtained from all patients entering the study.

2.2. Surgical procedure and post-operative management
Following median sternotomy, the ITAs were harvested as pedicled conduits; side branches were extensively clipped and electrocautery was avoided in order to prevent any thermal injury. The first intercostal branch and the distal bifurcation were systematically preserved. After systemic heparinization, both the ITAs were divided distally and a solution of papaverine hydrochloride (200 mg of papaverine in 100 ml of normal saline) was applied topically. In Group 1 the harvesting of both ITAs was avoided in patients with insulin-dependent diabetes mellitus with clinical evidence of microangiopathies, obesity (BMI>30) and chronic obstructive lung disease associated with severe emphysema and/or long standing steroid treatment.

In patients scheduled for radial artery (RA) harvesting, a pre-operative evaluation of the non-dominant arm (Allen test, oximetric plethysmography curve of the thumb during RA occlusion) was performed in order to assess the adequacy of collateral blood flow from the ulnar artery. In order to minimize RA wall damage and to prevent the risk of spasm, RA was harvested preserving satellite veins and surrounding connective tissue. After heparinization, the RA was divided distally, papaverine hydrochloride was injected intraluminally and a titanium clip was applied on the distal end. The RA was maintained in situ until the related coronary had to be performed in order to avoid arterial damage and spasm due to unnecessary storage.

Composite arterial grafts were realized by means of an end-to-side anastomosis (8/0 polypropylene running suture) of the RITA and/or RA in a Y/T graft fashion to the in situ LITA, always prior to cardiopulmonary bypass (CPB). Three different configurations were used to realize the composite grafts.

2.2.1. Type 1 configuration
The RITA is anastomosed as Y graft to the in situ LITA while the RA is used as a free graft for the right coronary system. This configuration was used in case of dominant, not occluded right coronary artery to avoid in such cases a composite graft totally dependent from the proximal LITA inflow (Fig. 1a ).



View larger version (20K):
[in this window]
[in a new window]
 
Fig. 1. (a–c) Different configurations of composite arterial grafts are shown (see the text for detailed explanations). LITA, left internal thoracic artery; RITA, right internal thoracic artery; RA, radial artery; LAD, left anterior descending; DIAG, diagonal branch; OM, obtuse marginal.

 
2.2.2. Type 2 configuration
The RA is anastomosed as a Y graft to the in situ LITA. This configuration, based on multiple sequential anastomoses, was carried out in case of a borderline stenosis of the obtuse marginal, occluded right coronary artery and in the presence of low run off of the target coronary vessels (Fig. 1b).

2.2.3. Type 3 configuration
Two segments of RA or/plus RITA are anastomosed end-to-side to the LITA, in order to obtain a double Y graft. This geometry was used when planned configuration type 1 or 2 could not be performed because of atheromatic lesions of the ascending aorta or unfavorable anatomy of the postero-lateral coronary vessels (Fig. 1c).

Cardiopulmonary bypass was instituted with a double-stage right atrial cannula for the venous line and cannulation of the ascending aorta for the arterial line, at a flow of 2.5 l/min/m2, maintaining a mean arterial blood pressure greater than 50 mmHg under mild hypothermia (33°C). Myocardial protection was achieved with intermittent antegrade and retrograde cold blood cardioplegia. Distal anastomoses were performed end-to-side or side-to-side (diamond-shaped configuration) with 8/0 polypropylene running suture. Proximal anastomoses were performed during rewarming under single aortic side clamping with a 6/0 (for saphenous vein grafts) or a 7/0 (for arterial conduits) polypropylene running suture. We avoided the use of the RITA as a free graft with proximal anastomosis on the ascending aorta. When the RA was used as a free graft, the proximal anastomosis was performed in most cases on a saphenous vein patch seamed on the ascending aorta.

In patients receiving RA grafts, Diltiazem was given orally the day before operation (60 mg every 8 h). During the operation, we administered an intravenous infusion of Diltiazem (mean dose: 0.5–1.5 µg/kg/min) which was continued for the first 48 h after surgery. Thereafter Diltiazem (120 mg per day) was administered orally for at least 6 months. After surgery, patients were managed in the intensive care unit (ICU) according to the standard unit protocol; water mattress rewarming was used until a nasopharyngeal temperature of 37°C was reached.

2.3. Patient follow-up and data analysis
End-points of this study were: early post-operative complications, recurrence of angina, graft occlusion and death. Patients were followed up at 2, 6 and 12 months; outpatient information were collected from patients' cardiologist and home physicians and by telephone interview.

Comparison of pre-operative and post-operative variables between the groups were analyzed using the Fisher exact test and the {chi}2 test for discrete variables and the unpaired t-test and the Mann–Whitney test for continuous variables; values for continuous variables were expressed as mean±standard deviation. A P-value less than 0.05 was considered to be significant.

Multivariate analysis and survival curves (Kaplan–Meier) were calculated using the StatSoft (Version 5.1, 1997 Edition, StatSoft Italia S.r.l.). Multivariate analysis was carried out using the Cox regression model for the time-dependent variables (recurrence of angina, myocardial infarction) and the multivariate logistic regression for time-independent variable (graft occlusion).


    3. Results
 Top
 Abstract
 1. Introduction
 2. Materials and methods
 3. Results
 4. Discussion
 Appendix A. Conference...
 References
 
3.1. Preoperative clinical characteristics
The preoperative baseline characteristics of the study population by treatment group are shown in Table 1. Univariate analysis of preoperative data and risk factors did not show any difference between the groups which resulted comparable for all continuous and discrete variables. As already reported by other authors, patients older than 70 years were more likely to have higher prevalence of renal dysfunction, cerebro-vascular disease, chronic obstructive pulmonary disease and diabetes when compared with younger CABG population [3,7].


View this table:
[in this window]
[in a new window]
 
Table 1. Preoperative Characteristics

 
Distribution of associated medical disease was similar to that reported from other authors [2,5], except for diabetes, whose prevalence was particularly high in the study population. In addition, the study groups showed a similar pre-operative high risk profile as detected by the risk assessment system Euroscore (G1: 8.4±2 vs. G2: 8.2±4).

3.2. Perioperative data
A total of 423 anastomoses were performed in 188 patients (G1: 206 vs. G2: 217). The mean number of anastomoses was similar between the groups (G1: 2.19±0.6 vs. G2: 2.31±0.3). In G1 composite arterial grafts configurations were as follows: type 2 configuration was used in the majority of patients (72%) while type 1 and 3 configurations were used in 8.5 and 19% of patients, respectively. The use of type 1 configuration, which includes the free graft anastomosis of the RA on the ascending aorta, was restricted to few cases without any atherosclerotic involvement of the ascending aorta.

Intraoperative data are shown in Table 3. There were no differences in terms of aortic cross-clamping time while cardiopulmonary bypass time was higher in G2 (G1: 60±17 min vs. G2: 84±39 min) reflecting the additional time required to perform SVGs proximal anastomoses.


View this table:
[in this window]
[in a new window]
 
Table 3. Early postoperative complications and mortality

 
There were neither any differences between the groups in terms of duration of mechanical ventilatory support and ICU stay (Table 2) nor there were any differences with respect to major postoperative complications and hospital mortality (Table 3).


View this table:
[in this window]
[in a new window]
 
Table 2. Perioperative data

 
The causes of death were similar between the groups. Five deaths occurred in G1 due to sepsis (two pts), multiple organ failure (two pts) and abdominal ischemia (one pt) while four pts died in G2 because of sepsis (two pts), multiple organ failure (one pt) and abdominal ischemia (one pt). Prolonged mechanical ventilation secondary to respiratory failure (two cases) and cerebro-vascular accidents (three cases) was the primary cause leading to sepsis and multiple organ failure.

Cerebro-vascular complications occurred in one patient in G1 (type 1 configuration) and in five patients in G2. All those patients underwent ascending aorta manipulation for proximal graft anastomosis. In addition to the listed complications (Table 3), eight patients (8.5%) in G2 had leg wound complications related to saphenous vein graft harvesting; among them, the incidence of diabetes was particularly high (75%). The incidence of blood transfusion was quite high in the study population without any difference between the groups (G1: 64% vs. G2: 61%, P=0.44).

3.3. Follow-up and late results
All the hospital survivors of G1 (89 pts) and G2 (90 pts) were evaluated by means of medical interview, clinical examination and cycloergometric test at 2, 6 and 12 months postoperatively. Mean duration of follow-up was 12±4 months without differences between the groups. Coronary angiography was carried out systematically in all patients with symptoms or with a positive or doubtful stress test (G1: two pts vs. G2: 11 pts). In addition, angiographic evaluation was carried out at random in 47 patients of G1 (50%) and 36 patients of G2 (38%). At the follow-up, the incidence of angina, percutaneous transluminal coronary angioplasty (PTCA) reintervention and graft occlusion were considerably lower in patients receiving total arterial revascularization (G1) (Table 4). Angiography showed three grafts occluded in G1 (one LITA to LAD and two RAs on the circumflex system) and 17 saphenous vein grafts occluded in G2 (10 SVGs on the right coronary system and seven SVGs on the circumflex system). The incidence of late death was comparable between the groups, while myocardial infarction was higher in G2 (G1: zero pts vs. G2: five pts) and near to reach statistical value (P=0.07). At 18 months the fraction of patients free from any recurrence of angina and/or myocardial infarction were considerably higher in G1 (Fig. 2A ). When the freedom from angina/myocardial infarction was analyzed with respect to the presence/absence of diabetes, the negative impact of diabetes on the mid-term clinical outcome was clearly evident especially in patients receiving saphenous vein grafts (Fig. 2B). The presence of hyperlipidemia also negatively affected the outcome of patients receiving SVGs, who showed an important worsening of the freedom from angina/myocardial infarction curve (Fig. 2C).


View this table:
[in this window]
[in a new window]
 
Table 4. Late complications (Follow up 12±4 months)

 


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 2. Survival curves (Kaplan–Meier) free from recurrence of angina and myocardial infarction. (A) Group 1 and Group 2 survival free from angina/MI curves are shown. (B) Survival curves are shown with respect to the presence of diabetes and the type of conduits used. (C) Survival curves are shown with respect to the presence of hyperlipidemia and the conduits used.

 
Multivariate logistic regression model was used to analyze the impact of saphenous vein grafts, gender, diabetes, hypertension and hyperlipidemia on graft occlusion: the presence of saphenous vein grafts (odds ratio: 1.15, 95% confidence interval: 1.07–1.23), diabetes (odds ratio: 1.17, 95% confidence interval: 1.10–1.24) and hyperlipidemia (odds ratio: 1.12, 95% confidence interval: 1.04–1.21) were identified as predictors for graft occlusion (Fig. 3 ).



View larger version (18K):
[in this window]
[in a new window]
 
Fig. 3. Variables predictive of graft occlusion (multivariate logistic regression analysis); confidence intervals are reported in the text.

 
When Cox proportional hazard model was used to evaluate the effects of the potentially related variables (presence of saphenous vein grafts, diabetes, hyperlipidemia, hypertension and gender) on the time occurrence of angina/myocardial infarction, diabetes (hazard ratio: 6.53, 95% confidence interval: 5.01–8.05), the presence of saphenous vein grafts (hazard ratio: 4.02, 95% confidence interval: 2.74–5.30) and hyperlipidemia (hazard ratio: 3.29, 95% confidence interval: 2.11–4.47) were identified as incremental risk factors (Fig. 4 ).



View larger version (14K):
[in this window]
[in a new window]
 
Fig. 4. Variables predictive of recurrence of angina (Cox regression analysis); confidence intervals are reported in the text.

 

    4. Discussion
 Top
 Abstract
 1. Introduction
 2. Materials and methods
 3. Results
 4. Discussion
 Appendix A. Conference...
 References
 
The age of patients undergoing CABG surgery has been steadily increasing over the past two decades, especially in the last two decades as a result of demographic changes related to increasing longevity and advances in medical care. The Society of Thoracic Surgeons database reported that in 10-year period (1980–1990) the average age increased from 58.5 to 64 years [8]; a similar trend has been shown in the last decade and nowadays the mean age of coronary patients is near to reach 70 years. As already demonstrated by several reports, cardiac surgery proved to be a safe and useful treatment for acquired heart disease in septuagenarians [911] and even in octogenarians [2,5,1214].

This cohort of patients may represent in the near future the largest fraction of the population undergoing CABG surgery, at least in the developed countries. Coronary surgery in elderly has been associated with increased perioperative morbidity and mortality when compared to younger populations [1416]. The higher operative risk in elderly seems to be not solely due to the aging process but mainly related to concomitant medical diseases and comorbidities [2].

In addition, previous studies demonstrated that elderly patients referred for CABG had more frequently disabling and unstable cardiac symptoms, compromised left ventricular function and more advanced coronary disease than younger patients [1719]. In an attempt to reduce the surgical invasiveness and risk in elderly patients, many surgeons have been reluctant to use arterial grafts, even the LITA to LAD, preferring an extensive use of the saphenous vein grafts.

Conversely, Morris et al. [5] reported in 1996 that the use of LITA on LAD in octogenarians clearly improved mid- and long-term outcome when compared to saphenous vein grafts, suggesting that arterial grafts may have a positive impact on the outcome even in very old patients.

An insight in this controversial issue came from recent reports which showed that operative morbidity and mortality of coronary surgery in elderly had steadily declined during the last few years as a result of advances in surgical and medical care [2,20].

Moreover, other recent studies focused on the use of multiple arterial grafts, demonstrating that arterial revascularization improved the outcome of patients undergoing CABG surgery, regardless the type of the arterial conduit used [21,22].

As a logical consequence of the previous observations, the clinical benefits of arterial revascularization may be extended to the elderly population without any increase in operative morbidity and mortality. Our study was designed in order to evaluate the safety and usefulness of total arterial revascularization in comparison with the conventional technique (LITA on LAD plus additional saphenous vein grafts).

In an attempt to avoid the risk of selection bias and to allow comparison of treatment strategies of equal patients subsets, this study was designed as a prospective randomized comparison and patients entering the study were almost consecutive and unselected. Left ventricular ejection fraction less than 25%, emergency operation, single vessel disease and patients with Euroscore >10 were the only exclusion criteria. High risk patients were excluded in order to avoid that their unpredictable distribution could affect the reliability of the study. Our study indicates that elderly patients receiving total arterial revascularization with composite grafts (G1) do not have any increase in morbidity and mortality when compared to the conventional CABG group (G2).

The use of arterial grafts did not prolong the aortic cross-clamping time; conversely, the mean duration of cardiopulmonary bypass was considerably higher in patients receiving saphenous vein grafts as a result of the additional time required for proximal anastomoses. Both groups showed near to identical hospital mortality (G1: 5.3% vs. G2: 4.2%, P=NS), which was lower than the predicted (Euroscore) and that reported in literature for comparable patients subset [2,14]. The causes of death, similar between the groups, were mainly related to prolonged ventilatory support caused by respiratory insufficiency and cerebro-vascular accidents which led to sepsis and multiple organ failure.

The use of full arterial revascularization in elderly did not increase post-operative complications: in particular, the rate of prolonged intubation, perioperative myocardial infarction, bleeding and sternal dehiscence was comparable between the groups.

Cerebro-vascular complications occurred in five patients receiving SVGs (G2) and only in one patient of G1: the difference did not reach statistical value but we believe that it may become significant in a larger cohort of patients.

The use of arterial revascularization with composite grafts (G1) was clearly associated with a better clinical outcome when compared with conventional coronary surgery: at a mean follow-up of 12±4 months patients in G1 had a significant lower incidence of angina recurrence, graft occlusion and PTCA reinterventions. As a result, patients undergoing arterial revascularization exhibited a better clinical outcome in terms of freedom from angina and myocardial infarction (Kaplan–Meier).

Our study also evaluates the impact of associated medical diseases on the outcome of elderly patients. Freedom from angina and myocardial infarction was lower in patients with diabetes and hyperlipidemia receiving saphenous vein grafts. Multivariate logistic stepwise regression analysis identified diabetes, saphenous vein grafts and hyperlipidemia as independent predictors for graft occlusion. The same variables were also found to be incremental risk factors for angina recurrence and myocardial infarction with the Cox regression model: the probability to develop new onset of myocardial ischemia was four and six times higher in patients with saphenous vein grafts and diabetes, respectively. At any point of the data analysis, there was evidence that patients receiving saphenous vein grafts had an higher incidence of late cardiac events when compared with patients receiving arterial grafts; in addition, the poor clinical outcome of saphenous vein grafts patients was worsened by the presence of diabetes and hyperlipidemia.

This study has some shortcomings mainly related to the small number of patients analyzed and to the fact that it was a single institution study. The latter influenced the characteristics of the study population which differed from that reported in literature for the very high prevalence of diabetes. In addition, a single institutional study carried out by few surgeons may account for additional bias related to surgical techniques, individual surgical skill and institutional quality of care.

In conclusion, this study suggests that TAMR in elderly is a safe procedure that may be performed without any increase in hospital morbidity and mortality. Technical pitfalls related to the use of arterial grafts may be overcome by using specific configurations of composite arterial conduits. Patients receiving arterial grafts showed a superior clinical outcome with a lower incidence of angina recurrence, myocardial infarction and graft occlusion, even at short term. The clinical benefits of total arterial revascularization were particularly evident in the presence of associated comorbidities very common in the elderly.


    Footnotes
 
Presented at the 16th Annual Meeting of the European Association for Cardio-thoracic Surgery, Monte Carlo, Monaco, September 22–25, 2002.


    Appendix A. Conference discussion
 Top
 Abstract
 1. Introduction
 2. Materials and methods
 3. Results
 4. Discussion
 Appendix A. Conference...
 References
 
Dr R. Dion (Leiden, The Netherlands): Did you decide before the operation to allocate the patient to type 1, type 2 or type 3 technique, or did you decide during the operation?

And the second question is: sometimes the physiologically old patients have a very fragile thoracic wall. When I am facing this condition, I prefer not to use the second mammary artery because I fear that the thoracic wall could be damaged. What are you doing in this situation?

Dr Muneretto: Concerning the first question, obviously the ideal configuration of composite arterial grafts was planned before the operation. Actually the majority of patients approximately 70%, received the type 2 configuration, that means one mammary artery and radial artery in a single Y graft. Sometimes the anatomy of the coronary artery makes this choice a challenge, as, for example, in the case of an important right dominant coronary artery. In this case we preferred to avoid a single inlet flow from LITA and we usually plan a type 1 configuration with a free radial artery graft on the right side. In some of those patients, at the beginning of the aortic manipulation or at the intraoperative echocardiography, some lesions of ascending aorta were founded making it necessary to move other type of configuration avoiding aortic manipulation.

Finally, sometimes that we planned on type 2 configuration, that is based on sequential anastomosis of radial artery on postero-lateral Vessels the angle between the coronary vessel or the diameters of coronary vessel make the sequential anastomosis a challenge. In this case we just cut in two pieces the radial artery and we move to the third configuration, a double Y graft that may avoid any technical pitfalls.

Could you please remind me your second question, please?

Dr Dion: About the fragility of the thoracic wall in very old patients.

Dr Muneretto: Yes, of course we were very concerned about the risk of sternal complication in high risk patients. However, the majority of patients, as I told you before, received only LITA and RA grafts. Anyhow, in those in which we harvested mammary arteries there was no evidences of an increase of sternal complication. This means that we didn't pay any price for the arterial revascularization. On the contrary it is very interesting to note that in patients older than 75 years old the incidence of leg complications related to saphenous vein graft harvesting ranged between 8% and 12%.

Dr S. Ghosh (Coventry, United Kingdom): Harping on what Dr. Dion said, what's your result about the harvesting bilateral mammaries in diabetics? What is the incidence of your stand-alone infection?

Dr Muneretto: We tried to avoid the double mammary harvesting in these type of patients. Basically a great majority of those patients underwent type 2 configuration, in which both mammary artery or radial artery were used in Y graft for total revascularization.

Dr D. Taggart (Oxford, United Kingdom): The only other comment I would make, we very much support in our own practice a policy of total arterial revascularization. But I think equally important in this population, these are the ones who will gain most by doing it off pump. And I think in this population, if you can do them off pump, then that's where you get a very significant reduction in morbidity, and particularly in the area of stroke, by totally avoiding manipulation of the aorta.

Dr Muneretto: I completely agree with you about the importance of OPCAB surgery in the elderly. This study was carried out to evaluate safety and usefulness of arterial graft in elderly in comparison with saphenous vein graft and did not have the purpose to analyze the usefulness of OPCAB procedures.

However, we strongly support the use of OPCAB especially in elderly and we are currently performing 80–85% of our coronary cases off pumps.

The use of composite graft prove to be an easy and effective technique of total revascularization especially in off pump surgery in which it allows an optimal length and mobilization of conduits avoiding any aortic manipulation.

Dr H. Sons (Kassel, Germany): Were all the operations performed by one surgeon, or did the more experienced surgeon perform the arterial grafts and the vein grafts were done by the resident?

Dr Muneretto: The study was performed basically by two surgeons, one performing full arterial grafting and the other one performing the conventional procedures. Both surgeons had a very wide experience in coronary surgery.

Dr S. Bose (Calcutta, India): My question is that I noticed that for the dominant right coronary artery, you're trying to put in a radial artery directly. You're not extending the LITA Y up to the right coronary artery. What has been the experiences when you extended the right internal mammary artery up to a dominant right coronary artery?

Dr Muneretto: We didn't experience any inconvenience in the use of a single inlet composite arterial graft in patients with dominant right coronary artery. The decision to avoid the single inlet in such patients was simply taken for precautionary reasons.


    References
 Top
 Abstract
 1. Introduction
 2. Materials and methods
 3. Results
 4. Discussion
 Appendix A. Conference...
 References
 

  1. Koutlas T.C., Elbeery J.R., Williams J.M., Moran J.F., Francalancia N.A., Chitwood R. Myocardial revascularisation in the elderly using beating heart coronary surgery. Ann Thorac Surg 2000;69:1042-1047.[Abstract/Free Full Text]
  2. Craver J.M., Puskas J.D., Weintraub W.W., Shen Y., Guyton R.A., Gott J.P., Jones E.L. 601 octogenarians undergoing cardiac surgery: outcome and comparison with younger age groups. Ann Thorac Surg 1999;67:1104-1110.[Abstract/Free Full Text]
  3. Ascione R., Rees K., Santo K., Chamberlain M.H., Marchetto G., Taylor F., Angelini G.D. Coronary artery bypass grafting in patients over 70 years old: the influence of age and surgical technique on early and mid-term clinical outcomes. Eur J Cardiothorac Surg 2002;22:124-128.[Abstract/Free Full Text]
  4. Lytle B.W., Blackstone E.H., Loop F.D., Houghtaling P.L., Arnold J.H., Akhrass R., McCarthy P.M., Cosgrove D.M. Two internal thoracic artery grafts are better than one. J Thorac Cardiovasc Surg 1999;117:855-872.[Abstract/Free Full Text]
  5. Morris R.J., Strong M.D., Grunewald K.E., Kuretu M.L.R., Samuels L.E., Kresh J.Y., Brockman S.K. Internal thoracic artery for coronary artery grafting in octogenarians. Ann Thorac Surg 1996;62:16-22.[Abstract/Free Full Text]
  6. Muneretto C., Negri A., Manfredi J., Terrini A., Bisleri G., Rodella G., ElQarra S. Safety and usefulness of composite grafts for total arterial myocardial revascularization: a prospective and randomised evaluation. J Thorac Cardiovasc Surg 2003;125:in press.
  7. Graham M.M., Ghali W., Faris P.D., Galbraith D., Norris C.M., Knudtson M.L. Survival after coronary revascularization in the elderly. Circulation 2002;105:2378-2384.[Abstract/Free Full Text]
  8. Edwards F.H., Clark R.E., Schwartz M. Coronary artery bypass grafting: the Society of Thoracic Surgeons national database experience. Ann Thorac Surg 1994;57:12-19.[Abstract]
  9. Loop F.D., Lytle B.W., Cosgrove D.M. Coronary artery bypass graft surgery in the elderly. Indications and outcome. Cleve Clin J Med 1988;55:23-24.[Medline]
  10. Lahey S.J., Borlase B.C., Lavin P.T., Levitsky S. Preoperative risk factors that predict hospital length of stay in patients older >60 years old. Circulation 1992;86(Suppl):II-181-IIhyphen185.
  11. He G.W., Acuff T.E., Ryan W.H., Bowman R.T., Douthit M.B., Mack M.J. Determinants of operative mortality in elderly patients undergoing coronary artery bypass grafting. Emphasis on the influence of internal mammary artery grafting on mortality and morbidity. J Thorac Cardiovasc Surg 1994;108:73-81.[Abstract/Free Full Text]
  12. Akins C.W., Daggett W.M., Vlahakes G.J., Hilgenberg A.D., Torchiana D.F., Madsen J.C., Buckley M.J. Cardiac operations in patients 80 years old and older. Ann Thorac Surg 1997;64:606-615.[Abstract/Free Full Text]
  13. Edmunds L.H., Jr, Stephenson L.W., Edie R.N., Ratcliffe M.B. Open-heart surgery in octogenarians. N Engl J Med 1988;319:131-136.[Abstract]
  14. Williams D., Carrillo R., Traad E.A., Wyatt C., Grahowki R., Wittels H., Ebra G. Determinants of operative mortality in octogenarians undergoing coronary bypass. Ann Thorac Surg 1995;60:1038-1043.[Abstract/Free Full Text]
  15. Noyez L., Van de Wal H.G. Perioperative morbidity and mortality of coronary artery surgery after the age of 70 years. J Cardiovasc Surg 1989;30:981-984.[Medline]
  16. Mohan R., Amsel B.J., Walter P.J. Coronary artery bypass grafting in the elderly: a review of studies on patients older than 64, 69 or 74 years. Cardiology 1992;80:215-223.[Medline]
  17. Tsai T., Chaux A., Matloff J.M. Ten years experience of cardiac surgery in patients aged 80 years and older. Ann Thorac Surg 1994;58:445-451.[Abstract]
  18. Weintraub W.S., Craver J.M., Cohen C.L., Jones E.L., Guyton R.A. Influence of age on results of coronary artery surgery. Circulation 1991;84(Suppl 3):226-235.
  19. Khan S., Kupfer J.M., Matloff J.M., Tsai T.P., Nessim S. Interaction of age and of pre-operative risk factors in predicting operative mortality for coronary bypass surgery. Circulation 1992;86(Suppl 2):186-190.
  20. Ivanov J., Weisel R.D., David T.E., Naylor D. Fifteen-year trends in risk severity and operative mortality in elderly patients undergoing coronary artery bypass graft surgery. Circulation 1998;97:673-680.[Abstract/Free Full Text]
  21. Calafiore A.M., Contini M., Vitella G., Di Mauro M., Mazzei V., Deodori G., Di Giammarco G. Bilateral internal thoracic artery grafting: long term clinical and angiographic results of in situ versus Y grafts. J Thorac Cardiovasc Surg 2000;120:990-998.[Abstract/Free Full Text]
  22. Royse A., Royse C.F., Raman J.S. Exclusive Y-graft operation for multi-vessel coronary revascularization. Ann Thorac Surg 1999;68:1612-1618.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Eur Heart JHome page
S. Damgaard, J. Wetterslev, J. T. Lund, N. B. Lilleor, M. J. Perko, H. Kelbaek, J. K. Madsen, and D. A. Steinbruchel
One-year results of total arterial revascularization vs. conventional coronary surgery: CARRPO trial
Eur. Heart J., April 2, 2009; 30(8): 1005 - 1011.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
F. Onorati, F. Pezzo, M. C. Comi, B. Impiombato, A. Esposito, M. Polistina, and A. Renzulli
Radial artery graft function is not affected by age.
J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1112 - 1120.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Matsuura, J. Kobayashi, O. Tagusari, K. Bando, K. Niwaya, H. Nakajima, T. Yagihara, and S. Kitamura
Off-Pump Coronary Artery Bypass Grafting Using Only Arterial Grafts in Elderly Patients
Ann. Thorac. Surg., July 1, 2005; 80(1): 144 - 148.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
G. Bisleri, T. Bottio, A. Manzato, and C. Muneretto
Epidural anesthesia for coronary artery bypass surgery
Eur. J. Cardiothorac. Surg., December 1, 2004; 26(6): 1228 - 1229.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
L. K. von Segesser
Creating innovative departments
Eur. J. Cardiothorac. Surg., December 1, 2004; 26(Suppl_1): S78 - S81.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Claudio Muneretto
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muneretto, C.
Right arrow Articles by Cas, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muneretto, C.
Right arrow Articles by Cas, L. D.
Related Collections
Right arrow Coronary disease


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS